Search
Health topic

Cardiovascular disease and cardiac biomarkers

Cardiovascular diseases are the number one cause of death globally.1

Worldwide, over 30% of all deaths are attributable to cardiovascular disease (CVD).1 The increasing incidence and high cost of care of CVDs demands a global approach to prevention, early detection & treatment, and monitoring of disease progression. Used in conjunction with clinical information, cardiac biomarkers are crucial to support rapid and accurate diagnosis, especially in acute cases where every minute counts.2-5

As market leader in cardiac biomarkers,6 Roche offers diagnostic tests for heart failure (HF), acute coronary syndrome (ACS), and atrial fibrillation (AF).

Partner with the pioneers for earlier, more confident clinical decision making.

 

Roche has been the pioneer in in vitro diagnostic tests for CVD decision making for over 30 years.  That’s why by partnering with Roche you get the benefit of our continual investment to enhance performance, clinical evidence, and reliability. This will support earlier & more confident clinical decision making, improved patient management, and increased efficiency & cost management.

Heart Failure

Roche NT-proBNP test:

The gold standard heart failure biomarker.7

Learn more

Acute Coronary Syndrome

Roche Troponin T-high sensitive:

Triage over 75% of chest pain patients in as little as 1 hour.8-10

Learn more

 

Roche CARDIAC POC Troponin T:

Faster triageing of patients with suspected acute myocardial infarction in pre-hospital care and emergency room.11,12

Learn more

Atrial Fibrillation

Roche GDF-15

Personalised bleeding-risk prediction for your AF patients.13

 

Do you have any questions?
Contact Us

Abbreviations

NT-proBNP: N-terminal prohormone of brain natriuretic peptide; POC: point of care

References

  1. World Health Organisation: http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). [Accessed October 2018, 13th]
  2. Roffi, M. et al. (2016). Eur Heart J 37(3), 267-315
  3. Rutten et al. https://ipccs.org/2017/12/10/epccs-practical-guidance-on-heart-failurediagnosis-and-management-in-primary-care/[Accessed on January 2018, 23rd]
  4. Ponikowski et al. (2016). Eur J Heart Fail. 18:891-975
  5. Yancy et al. (2017). Circulation. 136(6):e137-e161
  6. Data on file. Roche Diagnostics International Ltd. 
  7. McKie and Burnett (2016). J Am Coll Cardiol. 68, 2437-2439
  8. Bandstein et al. (2014). J Am Coll Cardiol. 63, 2569-78
  9. Body et al. (2015). Clin Chem. 61, 983-939
  10. Rubini-Giménez et al. (2013). Int J Cardiol. 168, 3896-3901
  11. Roche CARDIAC POC Troponin T- Method Sheet-package insert 
  12. Stengaard et al. (2013). Am J Cardiol. 112, 1361-1366
  13. Hijazi et al. (2016). Lancet. 387, 2302-2311
Found 0 results in
Search
Filters
...
    ...
    This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Please also be aware that the information in this website should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination.
    ©2020 F. Hoffmann-La Roche Ltd. All trademarks used or mentioned on this Website are protected by law.